Food and Drug Administration Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development; Public Meeting; Request for Comments

Короткий зміст

The Food and Drug Administration (FDA or the Agency) is announcing a public meeting and an opportunity for public comment on "FDA Rare Disease Day 2020: Supporting the Future of Rare Disease Product Development." Developing a treatment for a rare disease can present unique challenges. The goal of this meeting is to obtain stakeholders' perspectives on challenges and solutions in rare disease product development and identify commonalities that can support product development across a variety of rare diseases.